Abstract: A system for haptic stimulation includes: an actuation subsystem having a set of actuators, a support subsystem, a rigid housing, a sensor subsystem, a control module, and an electrical subsystem. A method for manufacturing a system for haptic stimulation includes performing a set of injection molding processes to form the support subsystem and/or the rigid housing; integrating the actuation subsystem within the support subsystem; and coupling the rigid housing to the support subsystem.

Abstract: A system for haptic stimulation includes: an actuation subsystem having a set of actuators, a support subsystem, a rigid housing, a sensor subsystem, a control module, and an electrical subsystem. A method for manufacturing a system for haptic stimulation includes performing a set of injection molding processes to form the support subsystem and/or the rigid housing; integrating the actuation subsystem within the support subsystem; and coupling the rigid housing to the support subsystem.

Abstract: A system for haptic stimulation includes: an actuation subsystem having a set of actuators, a support subsystem, a rigid housing, a sensor subsystem, a control module, and an electrical subsystem. A method for manufacturing a system for haptic stimulation includes performing a set of injection molding processes to form the support subsystem and/or the rigid housing; integrating the actuation subsystem within the support subsystem; and coupling the rigid housing to the support subsystem.

Abstract: Various embodiments of the invention provide human cell adhesion and extracellular matrix proteins (CADECM) and polynucleotides which identify and encode CADECM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.

Abstract: Various embodiments of the invention provide human cell adhesion and extracellular matrix proteins (CADECM) and polynucleotides which identify and encode CADECM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.

Abstract: Various embodiments of the invention provide human lipid-associated molecules (LIPAM) and polynucleotides which identify and encode LIPAM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LIPAM.

Abstract: Various embodiments of the invention provide human immune response associated proteins (IRAP) and polynucleotides which identify and encode IRAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of IRAP.

Abstract: Various embodiments of the invention provide human carbohydrate-associated proteins (CHOP) and polynucleotides which identify and encode CHOP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CHOP.

Abstract: Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.

Abstract: Various embodiments of the invention provide human molecules for disease detection and treatment (MDDT) and polynucleotides which identify and encode MDDT. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MDDT.

Abstract: The electrically heated hand grip includes a hand grip, a heating member disposed within the hand grip, an end cap assembly removably attached to the hand grip, and an electrical switch coupled to a power source for controlling the supply of current to the heating member. The end cap assembly includes a receptacle for receiving the power source and an electrical connecting means. The end cap assembly may include a light-emitting diode and a charging means. In an alternative embodiment, the electrically heated hand grip includes a resilient strip having a heating member attached to an interior surface of the resilient strip to form a heating strip. The heating strip is spirally wrapped about a grip-receiving portion of a shaft. An end cap assembly is coupled to the end of a shaft to secure a portion of the heating strip. The heated hand grip can include a sleeve which is inserted on the end of a shaft and the heating strip is spirally wrapped about the sleeve.

Abstract: Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.

Abstract: Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Abstract: A Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.

Abstract: Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.

Abstract: Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode-ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.

Abstract: Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.

Abstract: Various embodiments of the invention provide human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.a.

Abstract: Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides whichidentify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.

Abstract: A digital gemstone measurement device includes a first caliper jaw fixed to a housing, a second caliper jaw movable relative to the first caliper jaw, an encoding wheel that rotates in response to linear motion of the second caliper jaw, a photosensor for sensing rotation of the encoding wheel and a microcomputer responsive to photosensor output signals for calculating the weight of a gemstone. A slotted rotary encoding wheel provides measurement resolution on the order of 0.01 millimeter. A spring-loaded pneumatic dashpot urges the caliper jaws together relatively slowly so as to avoid snap-action. The gemstone shape is selected from a list, and the weight is calculated from a predetermined formula corresponding to the shape. The device is handheld and includes a keypad for controlling operation and an alphanumeric display for readout of measurement results.